Press Releases

Stay abreast of the news from ClearNote Health.

We are proud of the clinical evidence, R&D achievements, and our five-year-long company development as Bluestar Genomics. Now, as a commercial-stage company, ClearNote Health continues to drive innovation in non-invasive cancer detection, with patient needs at the core of everything we pursue.

Epigenomics-based Tests for Early Cancer Detection